SEC Company Response from PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — May 4, 2010
PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: May 4, 2010 · CIK: 0001357459 · Accession: 0001144204-10-024192
AI Filing Summary & Sentiment
File numbers found in text: 333-165973
Show Raw Text
CORRESP
1
filename1.htm
NEURALSTEM,
INC.
______________________________________________________
May 4,
2010
Jeffrey
P. Riedler
Assistant
Director
Division
of Corporation Finance
Mail Stop
6010
United
States Securities and Exchange Commission
Washington,
DC 20549
RE:
Neuralstem,
Inc. (“Issuer”)
Registration
Statement on Form S-3
Initially
Filed April 9, 2010
Amended
Filed April 27, 2010
File
No. 333-165973
Dear Mr.
Riedler:
Based
upon a telephone conversation with your staff, Neuralstem, Inc. is hereby
requesting the above referenced registration statement be declared effective at
1:00 p.m. EST, on Thursday, May 6, 2010 or as soon as practicable
thereafter.
We hereby
acknowledge that:
1.
should
the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, such action will not foreclose the
Commission from taking any action with respect to the
filing;
2.
the
action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, will not relieve the Issuer
from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
3.
The
Issuer may not assert staff comments and the declaration of effectiveness
as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United
States.
Very
truly yours,
/s/
I. Richard Garr
I. Richard
Garr
Chief
Executive Officer